Cesca Therapeutics Inc. (NASDAQ:KOOL)
Cesca Therapeutics Inc. (NASDAQ:KOOL) represented a move of 0 percent or $0 per share and closed its previous day trading session at $0.34. 0 Shares were traded in the last trading session with an Average Volume of 459.55 Million Shares. The stock currently has a Market Capitalization of 7.04 Million.
Cesca Therapeutics Inc. is engaged in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It also develops and manufactures automated blood and bone marrow processing systems and companion disposable products that enable the separation, processing and preservation of cell and tissue therapy products. The Company sells its products in approximately 30 countries throughout the world to customers that include private and public cord blood banks, surgeons, hospitals and research institutions. Cesca Therapeutics Inc., formerly known as ThermoGenesis Corp., is headquartered in Rancho Cordova, California.
The stock traded between $0.220 and $3.920 over 1-Year time period showing its price to sales ratio of 0.71. Cesca Therapeutics Inc. (NASDAQ:KOOL) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $0.14 and 200-Day Simple Moving Average of $-61.72. Its Price to Free Cash Flow is 0 and Price to Book of 0.49.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Cesca Therapeutics Inc. (NASDAQ:KOOL) reported its Actual EPS of $-0.12/share. The analysts offering Earnings Estimates for the company were believing that Cesca Therapeutics Inc. could bring EPS of $-0.1/share. The difference between Actual EPS and Estimated EPS was -0.02 Percent. Thus showing an Earnings Surprise of -20 Percent.
SIGA Technologies Inc. (NASDAQ:SIGA)
In the last trading session, SIGA Technologies Inc. (NASDAQ:SIGA) added its value by 0% closing at the price of $5.81. The stock currently has market capitalization of 458.47 Million, with average volume of 197.94 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently SIGA Technologies Inc. (NASDAQ:SIGA) is showing beta of 1.22. This particular value of beta suggests that SIGA Technologies Inc. (NASDAQ:SIGA) has historically moved 122% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for SIGA Technologies Inc. (NASDAQ:SIGA) is at $4.31.
The stock currently has RSI of 54.77. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA’s product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
SIGA Technologies Inc. (NASDAQ:SIGA) topped its 52-week high price of $8.47 on 08/22/18 and 52-Week Low Price of $3.90 on 12/12/17. The Stock currently has P/E (price to earnings ttm) of 1.35 and Weekly volatility of 7.00% and monthly volatility of 6.91% respectively.